Atara Biotherapeutics, Inc. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. for September 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 43.08 | 13,500 | 581,580 | 286,355 | 299.9 K to 286.4 K (-4.50 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 41.23 | 3,500 | 144,305 | 299,855 | 303.4 K to 299.9 K (-1.15 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.26 | 10,000 | 402,600 | 303,355 | 313.4 K to 303.4 K (-3.19 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.53 | 3,931 | 159,323 | 313,355 | 317.3 K to 313.4 K (-1.24 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.74 | 14,069 | 559,102 | 317,286 | 331.4 K to 317.3 K (-4.25 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 39.85 | 79,328 | 3,161,221 | 733,285 | 812.6 K to 733.3 K (-9.76 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Payment of Exercise | F | 39.85 | 22,158 | 882,996 | 243,966 | 266.1 K to 244 K (-8.33 %) |
| Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.99 | 3,900 | 155,961 | 58,678 | 62.6 K to 58.7 K (-6.23 %) |
| Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.62 | 3,900 | 154,518 | 62,578 | 66.5 K to 62.6 K (-5.87 %) |
| Sep 12 2018 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 41.05 | 16,500 | 677,325 | 16,500 | |
| Sep 11 2018 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Buy | P | 36.80 | 2,000 | 73,600 | 47,000 | 45 K to 47 K (+4.44 %) |
| Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.23 | 1,827 | 73,500 | 66,478 | 68.3 K to 66.5 K (-2.67 %) |
| Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.74 | 2,073 | 82,381 | 68,305 | 70.4 K to 68.3 K (-2.95 %) |
| Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.42 | 1,120 | 44,150 | 70,378 | 71.5 K to 70.4 K (-1.57 %) |
| Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.45 | 2,780 | 106,891 | 71,498 | 74.3 K to 71.5 K (-3.74 %) |
| Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | M | 20.40 | 1,500 | 30,600 | 77,000 | |
| Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 40.04 | 498 | 19,940 | 31,858 | 32.4 K to 31.9 K (-1.54 %) |
| Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Sell | S | 39.16 | 1,002 | 39,238 | 32,356 | 33.4 K to 32.4 K (-3.00 %) |
| Sep 05 2018 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Buy | M | 20.40 | 1,500 | 30,600 | 33,358 | 31.9 K to 33.4 K (+4.71 %) |